Chris MacDonald

Chris MacDonald

InvestorPlace Contributor

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

ANCN Stock: 10 Things to Know as Anchiano Therapeutics Rockets Higher

By Chris MacDonald, InvestorPlace Contributor

ANCN stock is an early stage company engaged in clinical trials for rare liver, lung and skin diseases with no FDA-approved options now.

CHK Stock: 2 Big Reasons Chesapeake Energy Is on the Move Today

By Chris MacDonald, InvestorPlace Contributor

Significant balance sheet improvements and a shift to natural gas make CHK stock an interesting deep value play for long-term investors now.

Why Sundial’s Parabolic Rise May Not Last

By Chris MacDonald, InvestorPlace Contributor

In the cannabis space, SNDL stock has soared of late. Here's why the company's astronomical rise might be short-lived.

Tesla Inc. Stock Will Continued to Slide for Awhile. Here’s Why

By Chris MacDonald, InvestorPlace Contributor

The debate about Tesla's ability to produce enough cash flow to cancel out the effect of the company's massive cash burn continues to be heated.

The Real Struggle for Tesla Inc Is Focus, Not Innovation

By Chris MacDonald, InvestorPlace Contributor

Tesla needs to be thinking of survival, not new car models. TSLA needs a laser-like focus on Model 3 production and nothing else.

Load More